U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce pelvic inflammatory disease in female adolescents and young women — STI‑07 Data Methodology and Measurement

On this page:  About the National Data  |  Methodology  |  History

About the National Data

Data

Data Source:  Healthcare Cost and Utilization Project - Nationwide Emergency Department Sample (HCUP-NEDS), AHRQ

Baseline: 205.7 visits per 100,000 females in 2018

Target: 137.3 per 100,000

Numerator
Estimated number of emergency department visits with an ICD-10-CM code indicating a PID diagnosis among females aged 15 to 24 years.
Denominator
Number of U.S. resident females aged 15 to 24 years.
Target-setting method
Maintain consistency with national programs, regulations, policies, or laws
Target-setting method justification
The target was selected to align with the 2030 target presented in the STI National Strategic Plan (STI Plan) for the indicator "Reduce PID in females aged 15–24 years by 6% by 2025 and 20% by 2030." The STI Plan Indicators subcommittee, in consultation with HHS leadership, set quantitative targets to reduce the rising rates of STIs as a public health threat by 2030. The approach to setting the annual target for all indicators that monitor disease rates (e.g., rates of PID) accounted for initial ramping up efforts, which would be slower. Thus, decreases in STI rates are expected to become more pronounced as the plan is implemented.

Methodology

Methodology notes

Emergency department visit records in HCUP NEDS where a pelvic inflamatory disease diagnosis was identified by ICD-10-CM codes A54.21, A54.24, A54.85, A56.11, A74.81, N70.01, N70.02, N70.03, N70.91, N70.92, N70.93, N71.0, N71.9, N73.0, N73.3, N73.5, N73.8, N73.9, or N74.

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People 2020 objective STD-5 in that objective STD-5 tracked females aged 15 to 44 years who have ever required treatment for pelvic inflammatory disease (PID), while this objective tracks females aged 15 to 24 years with PID.
Revision History
Revised. 

The baseline was updated from 2017 to 2018 and the target was revised from percent improvement to maintain consistency with national programs, regulations, policies or laws in order to align the objective with the STI National Strategic Plan (STI Plan) in 2021.